🕒 Thursday 22 May 2025 Thu, 22 May 2025

80 Articles

NFM Fast-Tracks Copper Production with Mt Kelly Processing Alliance

New Frontier Minerals advances its NWQ Copper Project by securing bulk sample processing at Austral Resources’ Mt Kelly plant, accelerating its path to copper production in Queensland’s Mt Isa Copper Belt.
22 May
Maxwell Dee
Maxwell Dee

AACo FY25 Profit Climbs 14% as Volume Growth Offsets Price Pressures

Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.
22 May
Ada Torres
Ada Torres

AACo Boosts FY25 Profit and Expands Premium Brands Amid Market Challenges

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.
22 May
Ada Torres
Ada Torres

AACo Posts 164% Surge in Operating Profit Amid Rising Sales

Australian Agricultural Company Limited (AACo) has reported a robust turnaround in its FY25 results, with significant gains in revenue and profitability driven by higher sales volumes and improved operational efficiency.
22 May
Ada Torres
Ada Torres

Oceania Healthcare Boosts EBITDA 4.1% and Unveils Bold Five-Year Strategy

Oceania Healthcare reported a 4.1% rise in underlying EBITDA for FY25, driven by strong sales and operational improvements, while launching a new strategic plan focused on growth and efficiency.
22 May
Ada Torres
Ada Torres

AFT Pharmaceuticals Eyes NZ$300M Revenue with Global Expansion Momentum

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.
22 May
Ada Torres
Ada Torres

AFT Pharmaceuticals Hits NZD 208M Revenue, Eyes NZD 300M by FY27

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.
22 May
Victor Sage
Victor Sage

AFT Pharmaceuticals Grows Revenue 6% Despite 23% Profit Slide

AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208 million for the year ending March 2025, but net profit fell 23%, prompting a modest final dividend declaration.
22 May
Ada Torres
Ada Torres